Stem cell therapy: An exercise in patience and prudence

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 368, Issue 1609, 2013, Pages

  Lin, Huan Ting ^a   Otsu, Makoto ^a   Nakauchi, Hiromitsu ^a  

^a THE UNIVERSITY OF TOKYO   (Japan)

Author keywords

Embryonic stem cells; Induced pluripotent stem cells; Pluripotency; Stem cells

Indexed keywords

BIOENGINEERING; CANCER; CYTOLOGY; DISEASE INCIDENCE; DISEASE TREATMENT; EMBRYO; GERM CELL; MEDICINE; PHYSIOLOGY; TECHNOLOGICAL DEVELOPMENT;

EID: 84869411713     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2011.0334     Document Type: Review

References (119)

1. Briggs R, King TJ. 1952 Transplantation of living nuclei from blastula cells into enucleated frogs' eggs. Proc. Natl Acad. Sci. USA 38, 455-463. (doi:10.1073/pnas.38.5.455)
2. Miller RA, Ruddle FH. 1976 Pluripotent teratocarcinoma-thymus somatic cell hybrids. Cell 9, 45-55. (doi:10.1016/0092-8674(76)90051-9)
3. Foshay KM et al. 2012 Embryonic stem cells induce pluripotency in somatic cell fusion through biphasic reprogramming. Mol. Cell 46, 159-170. (doi:10. 1016/j.molcel.2012.02.013)
4. Till JE, McCulloch CE. 1961 A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14, 213-222. (doi:10. 2307/3570892)
5. Metcalf D. 2007 Concise review: hematopoietic stem cells and tissue stem cells: current concepts and unanswered questions. Stem Cells 25, 2390-2395. (doi:10.1634/stemcells.2007-0544)
6. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM 1998 Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147. (doi:10.1126/science.282.5391.1145)
7. Evans M. 2011 Discovering pluripotency: 30 years of mouse embryonic stem cells. Nat. Rev. Mol. Cell Biol. 12, 680-686. (doi:10.1038/nrm3190)
8. Takahashi K, Yamanaka S. 2006 Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676. (doi:10.1016/j.cell.2006.07.024)
9. Weissman IL. 2000 Stem cells: units of development, units of regeneration, and units in evolution. Cell 100, 157-168. (doi:10.1016/S0092-8674(00)81692-X)
10. Seita J, Rossi DJ, Weissman IL. 2010 Differential DNA damage response in stem and progenitor cells. Cell Stem Cell 7, 145-147. (doi:10.1016/j.stem. 2010.07.006)
11. Martino G, Pluchino S. 2006 The therapeutic potential of neural stem cells. Nat. Rev. Neurosci. 7, 395-406. (doi:10.1038/nrn1908)
12. Van Keymeulen A, Blanpain C. 2012 Tracing epithelial stem cells during development, homeostasis, and repair. J. Cell Biol. 197, 575-584. (doi:10.1083/jcb.201201041)
13. Blanpain C, Horsley V, Fuchs E. 2007 Epithelial stem cells: turning over new leaves. Cell 128, 445-458. (doi:10.1016/j.cell.2007.01.014)
14. Pinnamaneni N, Funderburgh JL. 2012 Concise review: stem cells in the corneal stroma. Stem Cells 30, 1059-1063. (doi:10.1002/stem.1100)
15. Barker N, van de Wetering M, Clevers H. 2008 The intestinal stem cell. Genes Dev. 22, 1856-1864. (doi:10.1101/gad.1674008)
16. Nakada D, Levi BP, Morrison SJ. 2011 Integrating physiological regulation with stem cell and tissue homeostasis. Neuron 70, 703-718. (doi:10.1016/j. neuron.2011.05.011)
17. Jones DL, Wagers AJ. 2008 No place like home: anatomy and function of the stem cell niche. Nat. Rev. Mol. Cell Biol. 9, 11-21. (doi:10.1038/nrm2319)
18. Wagers AJ. 2012 The stem cell niche in regenerative medicine. Cell Stem Cell 10, 362-369. (doi:10. 1016/j.stem.2012.02.018)
19. Goritz C, Frisen J. 2012 Neural stem cells and neurogenesis in the adult. Cell Stem Cell 10, 657-659. (doi:10.1016/j.stem.2012. 04.005)
20. Keating A. 2012 Mesenchymal stromal cells: new directions. Cell Stem Cell 10, 709-716. (doi:10. 1016/j.stem.2012.05.015)
21. Grompe M. 2012 Tissue stem cells: new tools and functional diversity. Cell Stem Cell 10, 685-689. (doi:10.1016/j.stem.2012.04.006)
22. Martin GR. 1981 Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl Acad. Sci. USA 78, 7634-7638. (doi:10.1073/pnas.78.12.7634)
23. Evans MJ, Kaufman MH. 1981 Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156. (doi:10.1038/292154a0)
24. Stadtfeld M, Hochedlinger K. 2010 Induced pluripotency: history, mechanisms, and applications. Genes Dev. 24, 2239-2263. (doi:10.1101/gad. 1963910)
25. Zhang SC, Wernig M, Duncan ID, Brustle O, Thomson JA. 2001 In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat. Biotechnol. 19, 1129-1133. (doi:10.1038/nbt1201-1129)
26. Takayama K et al. 2012 Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4alpha transduction. Mol. Ther. 20, 127-137. (doi:10.1038/mt.2011.234)
27. Chadwick K, Wang L, Li L, Menendez P, Murdoch B, Rouleau A et al. 2003 Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 102, 906-915. (doi:10. 1182/blood-2003-03-0832)
28. Ben-David U, Benvenisty N. 2011 The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat. Rev. Cancer 11, 268-277. (doi:10.1038/nrc3034)
29. Swijnenburg RJ et al. 2008 Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc. Natl Acad. Sci. USA 105, 12 991-12 996. (doi:10.1073/pnas.0805802105)
30. Rosenthal E. 2006 Excommunication is sought for stem cell researchers. NY Times (Print), A3. 1st July, 2006.
31. Tanne JH. 2006 Bush vetoes bill to expand stem cell research. Br. Med. J. 333, 216. (doi:10.1136/bmj. 333.7561.216-b)
32. Gurdon JB, Wilmut I. 2011 Nuclear transfer to eggs and oocytes. Cold Spring Harb. Perspect. Biol. 3, pii: a002659. (doi:10.1101/cshperspect.a002659)
33. Tada M, Takahama Y, Abe K, Nakatsuji N, Tada T. 2001 Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr. Biol. 11, 1553-1558. (doi:10.1016/S0960-9822(01)00459-6)
34. Masui S et al. 2007 Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol. 9, 625-635. (doi:10.1038/ncb1589)
35. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. 2007 Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872. (doi:10. 1016/j.cell.2007.11.019)
36. Yu J et al. 2007 Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920. (doi:10.1126/science.1151526)
37. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. 2008 Induced pluripotent stem cells generated without viral integration. Science 322, 945-949. (doi:10.1126/science.1162494)
38. Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M. 2009 Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn. Acad. Ser. B. Phys. Biol. Sci. 85, 348-362. (doi:10.2183/pjab.85.348)
39. Liu H, Ye Z, Kim Y, Sharkis S, Jang YY. 2010 Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology 51, 1810-1819. (doi:10.1002/hep.23626)
40. Robinton DA, Daley GQ. 2012 The promise of induced pluripotent stem cells in research and therapy. Nature 481, 295-305. (doi:10.1038/nature10761)
41. Booth C, Gaspar HB, Thrasher AJ. 2011 Gene therapy for primary immunodeficiency. Curr. Opin. Pediatr. 23, 659-666. (doi:10.1097/MOP. 0b013e32834cd67a)
42. Colman A, Dreesen O. 2009 Pluripotent stem cells and disease modeling. Cell Stem Cell 5, 244-247. (doi:10.1016/j.stem.2009.08.010)
43. Daley GQ. 2012 The promise and perils of stem cell therapeutics. Cell Stem Cell 10, 740-749. (doi:10. 1016/j.stem.2012.05.010)
44. Newman AM, Cooper JB. 2010 Lab-specific gene expression signatures in pluripotent stem cells. Cell Stem Cell 7, 258-262. (doi:10.1016/j.stem.2010.06.016)
45. He S, Nakada D, Morrison SJ. 2009 Mechanisms of stem cell self-renewal. Annu. Rev. Cell Dev. Biol. 25, 377-406. (doi:10.1146/annurev.cellbio.042308. 113248)
46. Lechner A, Habener JF. 2003 Stem/progenitor cells derived from adult tissues: potential for the treatment of diabetes mellitus. Am. J. Physiol. Endocrinol. Metab. 284, E259-E266. (doi:10.1152/ajpendo.00393.2002)
47. Shortt AJ, Secker GA, Notara MD, Limb GA, Khaw PT, Tuft SJ, Daniels JT. 2007 Transplantation of ex vivo cultured limbal epithelial stem cells: a review of techniques and clinical results. Surv. Ophthalmol. 52, 483-502. (doi:10. 1016/j.survophthal.2007.06.013)
48. Fuchs E. 2008 Skin stem cells: rising to the surface. J. Cell Biol. 180, 273-284. (doi:10.1083/jcb. 200708185)
49. Weissman IL, Shizuru JA. 2008 The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood 112, 3543-3553. (doi:10.1182/blood-2008-08-078220)
50. Okabe M et al. 2009 Definitive proof for direct reprogramming of hematopoietic cells to pluripotency. Blood 114, 1764-1767. (doi:10.1182/blood-2009-02-203695)
51. Osawa M, Hanada K, Hamada H, Nakauchi H. 1996 Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273, 242-245. (doi:10.1126/science.273.5272.242)
52. Orkin SH, Zon LI. 2008 Hematopoiesis: an evolving paradigm for stem cell biology. Cell 132, 631-644. (doi:10.1016/j.cell.2008.01.025)
53. Seita J, Weissman IL. 2010 Hematopoietic stem cell: self-renewal versus differentiation. Wiley Interdiscip. Rev. Syst. Biol. Med. 2, 640-653. (doi:10.1002/wsbm.86)
54. Copelan EA. 2006 Hematopoietic stem-cell transplantation. N. Engl. J. Med. 354, 1813-1826. (doi:10.1056/NEJMra052638)
55. Little MT, Storb R. 2002 History of haematopoietic stem-cell transplantation. Nat. Rev. Cancer 2, 231-238. (doi:10.1038/nrc748)
56. Doulatov S, Notta F, Laurenti E, Dick JE. 2012 Hematopoiesis: a human perspective. Cell Stem Cell 10, 120-136. (doi:10.1016/j.stem.2012.01.006)
57. Greenberger JS. 2008 Gene therapy approaches for stem cell protection. Gene Ther. 15, 100-108. (doi:10.1038/sj.gt.3303004)
58. Gaspar HB et al. 2011 Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction. Sci. Transl. Med. 3, 97ra80. (doi:10.1126/scitranslmed.3002716)
59. Kang HJ et al. 2011 Retroviral gene therapy for Xlinked chronic granulomatous disease: results from phase I/II trial. Mol. Ther. 19, 2092-2101. (doi:10. 1038/mt.2011.166)
60. Galy A, Thrasher AJ. 2011 Gene therapy for the Wiskott-Aldrich syndrome. Curr. Opin. Allergy Clin. Immunol. 11, 545-550. (doi:10.1097/ACI. 0b013e32834c230c)
61. Hacein-Bey-Abina S et al. 2003 LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415-419. (doi:10.1126/science.1088547)
62. Lindvall O. 2012 Why is it taking so long to develop clinically competitive stem cell therapies for CNS disorders? Cell Stem Cell 10, 660-662. (doi:10. 1016/j.stem.2012.04.004)
63. Fuentealba LC, Obernier K, Alvarez-Buylla A. 2012 Adult neural stem cells bridge their niche. Cell Stem Cell 10, 698-708. (doi:10.1016/j.stem. 2012.05.012)
64. Martino G, Bacigaluppi M, Peruzzotti-Jametti L. 2011 Therapeutic stem cell plasticity orchestrates tissue plasticity. Brain 134, 1585-1587. (doi:10. 1093/brain/awr115)
65. Blanpain C, Fuchs E. 2006 Epidermal stem cells of the skin. Annu. Rev. Cell Dev. Biol. 22, 339-373. (doi:10.1146/annurev.cellbio.22.010305.104357)
66. Nguyen H, Merrill BJ, Polak L, Nikolova M, Rendl M, Shaver TM, Pasolli HA, Fuchs E. 2009 Tcf3 and Tcf4 are essential for long-term homeostasis of skin epithelia. Nat. Genet. 41, 1068-1075. (doi:10. 1038/ng.431)
67. Arwert EN, Hoste E, Watt FM. 2012 Epithelial stem cells, wound healing and cancer. Nat. Rev. Cancer 12, 170-180. (doi:10.1038/nrc3217)
68. Green H. 2008 The birth of therapy with cultured cells. Bioessays 30, 897-903. (doi:10. 1002/bies.20797)
69. Mavilio F et al. 2006 Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat. Med. 12, 1397-1402. (doi:10.1038/nm1504)
70. Radtke F, Clevers H. 2005 Self-renewal and cancer of the gut: two sides of a coin. Science 307, 1904-1909. (doi:10.1126/science.1104815)
71. Sato T et al. 2009 Single Lgr5 stem cells build cryptvillus structures in vitro without a mesenchymal niche. Nature 459, 262-265. (doi:10.1038/nature07935)
72. Yui S et al. 2012 Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5({thorn}) stem cell. Nat. Med. 18, 618-623. (doi:10.1038/nm.2695)
73. Shaker A, Rubin DC. 2012 Stem cells: one step closer to gut repair. Nature 485, 181-182. (doi:10. 1038/485181a)
74. Takacs L, Toth E, Berta A, Vereb G. 2009 Stem cells of the adult cornea: from cytometric markers to therapeutic applications. Cytometry A 75, 54-66. (doi:10.1002/cyto.a.20671)
75. Daniels JT, Dart JK, Tuft SJ, Khaw PT. 2001 Corneal stem cells in review. Wound Repair Regen. 9, 483-494. (doi:10.1046/j.1524-475x.2001.00483.x)
76. Pellegrini G, Rama P, Mavilio F, De Luca M. 2009 Epithelial stem cells in corneal regeneration and epidermal gene therapy. J. Pathol. 217, 217-228. (doi:10.1002/path.2441)
77. Caplan AI. 1991 Mesenchymal stem cells. J. Orthop. Res. 9, 641-650. (doi:10.1002/jor.1100090504)
78. Horwitz EM, Dominici M. 2008 How do mesenchymal stromal cells exert their therapeutic benefit? Cytotherapy 10, 771-774. (doi:10.1080/14653240802618085)
79. Mizuno H, Tobita M, Uysal AC. 2012 Concise review: adipose-derived stem cells as a novel tool for future regenerative medicine. Stem Cells 30, 804-810. (doi:10.1002/stem.1076)
80. da Silva Meirelles L, Chagastelles PC, Nardi NB. 2006 Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. 119, 2204-2213. (doi:10.1242/jcs.02932)
81. Ra JC et al. 2011 Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev. 20, 1297-1308. (doi:10.1089/scd.2010.0466)
82. Uccelli A, Moretta L, Pistoia V. 2008 Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8, 726-736. (doi:10.1038/nri2395)
83. Pittenger MF et al. 1999 Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147. (doi:10.1126/science.284.5411.143)
84. Kebriaei P, Robinson S. 2011 Treatment of graftversus-host-disease with mesenchymal stromal cells. Cytotherapy 13, 262-268. (doi:10.3109/14653249.2010.549688)
85. Kim K et al. 2010 Epigenetic memory in induced pluripotent stem cells. Nature 467, 285-290. (doi:10.1038/nature09342)
86. Lister R et al. 2011 Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471, 68-73. (doi:10.1038/nature09798)
87. Chen AE et al. 2009 Optimal timing of inner cell mass isolation increases the efficiency of human embryonic stem cell derivation and allows generation of sibling cell lines. Cell Stem Cell 4, 103-106. (doi:10.1016/j.stem.2008.12.001)
88. Niakan KK, Han J, Pedersen RA, Simon C, Pera RA. 2012 Human pre-implantation embryo development. Development 139, 829-841. (doi:10. 1242/dev.060426)
89. Varela E, Schneider RP, Ortega S, Blasco MA. 2011 Different telomere-length dynamics at the inner cell mass versus established embryonic stem (ES) cells. Proc. Natl Acad. Sci. USA 108, 15 207-15 212. (doi:10.1073/pnas.1105414108)
90. Yamanaka S. 2012 Induced pluripotent stem cells: past, present, and future. Cell Stem Cell 10, 678-684. (doi:10.1016/j.stem.2012.05.005)
91. Takahashi K, Mitsui K, Yamanaka S. 2003 Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature 423, 541-545. (doi:10.1038/nature01646)
92. Osafune K, Caron L, Borowiak M, Martinez RJ, Fitz-Gerald CS, Sato Y, Cowan CA, Chien KR, Melton DA. 2008 Marked differences in differentiation propensity among human embryonic stem cell lines. Nat. Biotechnol. 26, 313-315. (doi:10.1038/nbt1383)
93. Whitworth KM, Prather RS. 2010 Somatic cell nuclear transfer efficiency: how can it be improved through nuclear remodeling and reprogramming? Mol. Reprod. Dev. 77, 1001-1015. (doi:10.1002/mrd.21242)
94. Tat PA, Sumer H, Pralong D, Verma PJ. 2011 The efficiency of cell fusion-based reprogramming is affected by the somatic cell type and the in vitro age of somatic cells. Cell Reprogram. 13, 331-344. (doi:10.1089/cell.2011.0002)
95. Hansson M, Madsen OD. 2010 Pluripotent stem cells, a potential source of beta-cells for diabetes therapy. Curr. Opin. Invest. Drugs 11, 417-425.
96. Naujok O, Burns C, Jones PM, Lenzen S. 2011 Insulin-producing surrogate beta-cells from embryonic stem cells: are we there yet? Mol. Ther. 19, 1759-1768. (doi:10.1038/mt.2011.165)
97. Kroon E et al. 2008 Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol. 26, 443-452. (doi:10.1038/nbt1393)
98. Chen LW, Kuang F, Wei LC, Ding YX, Yung KK, Chan YS. 2011 Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease. CNS Neurol. Disord. Drug Targets 10, 449-458.
99. Baker M. 2009 Stem cells: fast and furious. Nature 458, 962-965. (doi:10.1038/458962a)
100. Grskovic M, Javaherian A, Strulovici B, Daley GQ. 2011 Induced pluripotent stem cells-opportunities for disease modelling and drug discovery. Nat. Rev. Drug Discov. 10, 915-929. (doi:10.1038/nrd3577)
101. Bagni C, Greenough WT. 2005 From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nat. Rev. Neurosci. 6, 376-387. (doi:10.1038/nrn1667)
102. Urbach A, Bar-Nur O, Daley GQ, Benvenisty N. 2010 Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 6, 407-411. (doi:10.1016/j.stem.2010.04.005)
103. Sheridan SD, Theriault KM, Reis SA, Zhou F, Madison JM, Daheron L, Loring JF, Haggarty SJ, Cookson MR. 2011 Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS ONE 6, e26203. (doi:10.1371/journal.pone. 0026203)
104. Onder TT, Daley GQ. 2012 New lessons learned from disease modeling with induced pluripotent stem cells. Curr. Opin. Genet. Dev. (doi:10.1016/j.gde. 2012.05.005)
105. Hanna J et al. 2007 Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318, 1920-1923. (doi:10. 1126/science.1152092)
106. Wang L, Menendez P, Shojaei F, Li L, Mazurier F, Dick JE, Cerdan C, Levac K, Bhatia M. 2005 Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression. J. Exp. Med. 201, 1603-1614. (doi:10.1084/jem.20041888)
107. Saleque S, Kim J, Rooke HM, Orkin SH. 2007 Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1. Mol. Cell 27, 562-572. (doi:10.1016/j.molcel.2007.06.039)
108. Lu SJ, Feng Q, Park JS, Lanza R. 2010 Directed differentiation of red blood cells from human embryonic stem cells. Methods Mol. Biol. 636, 105-121. (doi:10.1007/978-1-60761-691-7_7)
109. Takayama N, Nishikii H, Usui J, Tsukui H, Sawaguchi A, Hiroyama T et al. 2008 Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood 111, 5298-5306. (doi:10.1182/blood-2007-10-117622)
110. Takayama N et al. 2010 Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J. Exp. Med. 207, 2817-2830. (doi:10.1084/jem.20100844)
111. Vierbuchen T, Wernig M. 2011 Direct lineage conversions: unnatural but useful? Nat. Biotechnol. 29, 892-907. (doi:10.1038/nbt.1946)
112. Jayawardena TM et al. 2012 MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ. Res. 110, 1465-1473. (doi:10.1161/CIRCRESAHA.112.269035)
113. Pang ZP et al. 2011 Induction of human neuronal cells by defined transcription factors. Nature 476, 220-223. (doi:10.1038/nature10202)
114. Szabo E, Rampalli S, Risueno RM, Schnerch A, Mitchell R, Fiebig-Comyn A, Levadoux-Martin M, Bhatia M. 2010 Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 468, 521-526. (doi:10.1038/nature09591)
115. Kobayashi T et al. 2010 Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells. Cell 142, 787-799. (doi:10. 1016/j.cell.2010.07.039)
116. Strauss S. 2010 Geron trial resumes, but standards for stem cell trials remain elusive. Nat. Biotechnol. 28, 989-990. (doi:10.1038/nbt1010-989)
117. Schwartz SD et al. 2012 Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379, 713-720. (doi:10.1016/S0140-673660028-2)
118. Cyranoski D. 2012 Stem-cell therapy takes off in Texas. Nature 483, 13-14. (doi:10.1038/483013a)
119. Smith A. 2011 'No' to ban on stem-cell patents. Nature 472, 418. (doi:10.1038/472418a)